Alluvi Retatrutide 20mg Trade Information
- Minimum Order Quantity
- 5 Vials
- Payment Terms
- Delivery Point (DP), Delivery Point (DP), Cheque, Cheque, Cash in Advance (CID), Cash in Advance (CID), Cash Advance (CA), Cash Advance (CA), Cash on Delivery (COD), Cash on Delivery (COD), Cash Against Delivery (CAD), Cash Against Delivery (CAD), Days after Acceptance (DA), Days after Acceptance (DA)
- Supply Ability
- 5 Vials Per Day
- Sample Policy
- Free samples are available
- Main Export Market(s)
- Asia, Asia, Central America, Central America, Australia, Australia, South America, South America, North America, North America, Eastern Europe, Eastern Europe, Western Europe, Western Europe, Middle East, Middle East
- Main Domestic Market
- All India, South India, Central India, West India, North India, East India, Gujarat, Karnataka, Kerala, Lakshadweep, Mizoram
Alluvi Retatrutide 20mg About
Alluvi Retatrutide 20mg is an unapproved, experimental peptide product marketed online mimicking retatrutidean investigational triple-hormone receptor agonist (GLP-1, GIP, and glucagon) still undergoing clinical trials for obesity and metabolic disorders